Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study-Reference-Cited by-同舟云学术

Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study

Published:2022-12-28 Issue:2 Volume:23 Page:241-250
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Pollack Charles V.¹,Agiro Abiy²,Mu Fan³,Cook Erin E.³^ORCID,Lemus Wirtz Esteban³,Young Joshua A.³,Betts Keith A.³,Brahmbhatt Yasmin G.²

Affiliation:

1. Emergency Medicine, University of Mississippi, Jackson, Mississippi, United States

2. US Medical Affairs, AstraZeneca, Wilmington, Delaware, United States

3. Health Economics and Outcomes Research, Analysis Group, Boston, Massachusetts

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2161514

Reference24 articles.

1. New options for the management of chronic hyperkalemia

2. How Dangerous Is Hyperkalemia?

3. The Cost of Hyperkalemia in the United States

4. Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related Hospitalizations

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coste-efectividad del ciclosilicato de sodio y zirconio para el tratamiento de la hiperpotasemia en pacientes con enfermedad renal crónica o insuficiencia cardiaca en España;Nefrología;2024-09

2. Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait;Journal of Medical Economics;2024-02-14

3. Management of Hyperkalemia in Patients with Chronic Kidney Disease Using Renin Angiotensin Aldosterone System Inhibitors;Current Hypertension Reports;2023-09-25

4. Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study;ClinicoEconomics and Outcomes Research;2023-09

5. Impact of Sodium Zirconium Cyclosilicate Plus Renin–Angiotensin–Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study;Advances in Therapy;2023-08-22